238 results on '"Ruutu, T"'
Search Results
2. Second allogeneic transplantation for relapse of malignant disease: retrospective analysis of outcome and predictive factors by the EBMT
3. Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives—a position statement from the European Society for Blood and Marrow Transplantation (EBMT)
4. ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IS FEASIBLE AFTER SOLID ORGAN TRANSPLANTATION: FINAL ANALYSIS BY THE EARLY COMPLICATIONS SUBCOMMITTEE OF THE COMPLICATIONS AND QUALITY OF LIFE WORKING PARTY, EBMT: PH-P351
5. A prospective registration study to determine feasibility of hematopoietic SCT in adults with acute leukemia: planning, expectations and reality
6. Prophylaxis and treatment of GVHD: EBMT-ELN working group recommendations for a standardized practice: This article has been corrected since Online Publication and a corrigendum has also been published
7. In a high-dose melphalan setting, palifermin compared with placebo had no effect on oral mucositis or related patientʼs burden
8. Prophylaxis and treatment of graft-versus-host disease: EBMT - ELN working group recommendations for a standardized practice: 296
9. Second allogeneic haematopoietic stem cell transplantation for relapse of malignant disease: retrospective analysis of outcome and predictive factors: 196
10. Impact of graft-versus-host disease on relapse after allogeneic stem cell transplantation: an EBMT megafile study: 200
11. Prophylaxis and treatment of GVHD after allogeneic haematopoietic SCT: a survey of centre strategies by the European Group for Blood and Marrow Transplantation
12. Allogeneic hematopoietic SCT in patients with AML following treosulfan/fludarabine conditioning
13. P636 Medical resource use of two different dosing regimens of palifermin to prevent mucositis in multiple myeloma patients receiving one-day administration of high-dose melphalan
14. Prophylaxis and treatment of graft-versus-host disease after allogeneic stem cell transplantation: a survey of centre strategies by the European Group for Blood and Marrow Transplantation: P443
15. Punctal occlusion for the treatment of severe dry eyes in patients after allogeneic stem cell transplantation: a non-interventional prospective study of the complications subcommittee of the Chronic Leukaemia Working party of the EBMT: 247
16. Topical tacrolimus in the treatment of cutaneous and mucosal manifestations of chronic GvHD: a noninterventional prospective study by the Complications Subcommittee of the Chronic Leukaemia Working Party of the EBMT: 248
17. Final results of the EBMT non-interventional prospective study in DMSO; DMSO reduction lessens side effects: O182
18. Early thrombin generation and impaired fibrinolysis after SCT associate with acute GVHD
19. Invasive Aspergillus infections in allo-SCT recipients: environmental sampling, nasal and oral colonization and galactomannan testing
20. Reduced-toxicity conditioning with treosulfan and fludarabine in allogeneic haematopoietic stem cell transplantation for myelodysplastic syndromes: final results of an international prospective phase II trial: O300
21. Standard and reduced-intensity allogeneic haematopoietic stem cell transplantation: O286
22. Allogeneic stem cell transplantation for Philadelphiapositive acute lymphoblastic leukaemia in recent years: a retrospective EBMT analysis of patients transplanted in first remission: O281
23. The DMSO survey - first analysis: 224
24. The effect of transfusions and iron toxicity on non-relapse mortality in patients with untreated adult MDS treated with myeloablative alloSCT: a retrospective study of the MDS subcommittee of the Chronic Leukaemia Working Party of the EBMT: 228
25. Unrelated allogeneic stem cell transplantation with myeloablative conditioning in adults with acute lymphoblastic leukaemia in remission: peripheral blood or bone marrow?: O137
26. Randomized comparison of bone marrow and peripheral blood stem cells for treatment of leukaemia - long-term follow-up results on survival, GvHD and late effects: 116
27. The Prospective Oral Mucositis Audit: relationship of severe oral mucositis with clinical and medical resource use outcomes in patients receiving high-dose melphalan or BEAM-conditioning chemotherapy and autologous SCT
28. The harvest and use of autologous back-up grafts for graft failure or severe GVHD after allogeneic hematopoietic stem cell transplantation: a survey of the European Group for Blood and Marrow Transplantation
29. Outcome of AML patients exhibiting isolated or associated trisomy 8 after allo-HSCT: a retrospective study on behalf of the Acute Leukaemia Working Party of the EBMT
30. Prospective evaluation of oral mucositis in allogeneic stem cell transplant recipients receiving conventional myeloablative conditioning or reduced-toxicity conditioning with treosulfan and fludarabine
31. Reduced-intensity versus conventional myeloablative conditioning allogeneic stem cell transplantation for patients with acute lymphoblastic leukaemia: a survey from the Acute Leukaemia Working Party of EBMT
32. Natural anticoagulation and endothelial markers in association with allogeneic stem cell transplantation and graft-versus-host disease
33. Haematopoietic stem cell transplantation in T-prolymphocytic leukaemia: a retrospective EBMT analysis
34. An open-label randomised study of oral valganciclovir versus intravenous ganciclovir for pre-emptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation
35. Reduced versus standard conditioning followed by allogeneic stem cell transplantation in MDS/sAML. A prospective randomised phase III study of the MDS subcommittee of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplant
36. Outcome of chronic myeloid leukaemia patients with allogeneic haematopoietic stem cell transplantation and a low risk score in the imatinib era. A report from the EBMT Chronic Leukemia Working Party and the European Leukemia Net
37. Update of the registration study
38. The utility of intensified environmental surveillance for pathogenic moulds in a stem cell transplantation ward during construction work to monitor the efficacy of HEPA filtration
39. Reduced-toxicity conditioning with fludarabine and treosulfan prior to allogeneic stem cell transplantation in multiple myeloma
40. A randomized study on donor immunization with tetanus-diphtheria, Haemophilus influenzae type b and inactivated poliovirus vaccines to improve the recipient responses to the same vaccines after allogeneic bone marrow transplantation
41. Variation in dimethyl sulfoxide use in stem cell transplantation: a survey of EBMT centres
42. Collection of autologous blood for bone marrow donation: how useful is it?
43. Retrospective comparison of reduced-intensity conditioning and conventional myeloablative conditioning for allogeneic haematopoietic stem cell transplantation using HLA identical sibling donors in myelodysplastic syndromes
44. Comparison between early and late immunisation with three doses of an heptavalent pneumococcal conjugate vaccine in allogeneic stem cell transplant recipients (EBMT IDPW01 trial)
45. Use of intrathecal prophylaxis in allogeneic haematopoietic stem cell transplantation for malignant blood diseases: a survey of the European Group for Blood and Marrow Transplantation (EBMT)
46. Candidaemia in allogeneic stem cell transplant recipients: low risk without fluconazole prophylaxis
47. Isolated HLA-C mismatches in unrelated donor transplantation for CML
48. Comparison between early and late immunisation with three doses of an heptavalent pneumococcal conjugate vaccine in allogeneic stem cell transplant recipients (EBMT IDPW01 trial)
49. Unrelated donor haematopoietic stem cell transplantation with myeloablative preparative regimens for the treatment of de novo acute myelogenous leukaemia in patients older than 44 years
50. Differences between graft product and donor side effects following bone marrow or stem cell donation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.